GUARDION HEALTH SCIENCES, INC. Liabilities, Fair Value Adjustment
GUARDION HEALTH SCIENCES, INC. reported Liabilities, Fair Value Adjustment of -$3.82 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2024-08-13
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for the quarter ending 2024-06-30 was -$549.32K.
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for the quarter ending 2024-03-31 was -$3.27M, a 272.20% decline year-over-year.
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for the quarter ending 2023-12-31 was $1.29M.
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for the quarter ending 2023-09-30 was $1.05M, a 20.34% increase year-over-year.
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for fiscal 2023 was $3.98M, a 69.87% increase from fiscal 2022.
- GUARDION HEALTH SCIENCES, INC. liabilities, fair value adjustment for fiscal 2022 was $2.35M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$549.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$3.82M 10-Q · filed 2024-08-13 | -$2.53M derived: sum of 3 quarters · filed 2024-08-13 | -$1.48M derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | -$3.27M 10-Q · filed 2024-05-13 | -$1.98M derived: sum of 2 quarters · filed 2024-05-13 | -$926.49K derived: sum of 3 quarters · filed 2024-05-13 | -$1.18M derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.34M derived: sum of 2 quarters · filed 2024-03-29 | $2.09M derived: sum of 3 quarters · filed 2024-03-29 | $3.98M 10-K · filed 2024-03-29 |
| 2023-09-30 | $1.05M 10-Q · filed 2023-11-13 | $795.50K derived: sum of 2 quarters · filed 2023-11-13 | $2.69M 10-Q · filed 2023-11-13 | $1.49M derived: sum of 4 quarters · filed 2024-03-29 |
| 2023-06-30 | -$255.30K 10-Q · filed 2023-08-14 | $1.64M 10-Q · filed 2023-08-14 | $440.30K derived: sum of 3 quarters · filed 2024-03-29 | $1.31M derived: sum of 4 quarters · filed 2024-03-29 |
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-15 | $695.60K derived: sum of 2 quarters · filed 2024-03-29 | $1.57M derived: sum of 3 quarters · filed 2024-03-29 | $6.93M derived: sum of 4 quarters · filed 2024-03-29 |
| 2022-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$329.30K derived: sum of 2 quarters · filed 2024-03-29 | $5.03M derived: sum of 3 quarters · filed 2024-03-29 | $2.35M 10-K · filed 2024-03-29 |
| 2022-09-30 | $873.20K 10-Q · filed 2023-11-13 | $6.23M derived: sum of 2 quarters · filed 2023-11-13 | $3.55M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $5.36M 10-Q · filed 2023-08-14 | $2.68M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$2.68M 10-Q · filed 2023-05-15 |